Jinhua Wen

机构：Nanchang University, Jiang Xi Institute for Drug Control, First Affiliated Hospital of Nanchang University · ORCID：0000-0003-3979-340X

发表论文 57 篇 · 总被引 692 次 · h-index 14

代表论文

• OATP1B1 Plays an Important Role in the Transport and Treatment Efficacy of Sorafenib in Hepatocellular Carcinoma (2021 · Disease Markers · 被引 16)
• A phase 1/2 study of LM-302, an anti-claudin 18.2 (CLDN18.2) antibody-drug conjugate in patients with advanced gastric/gastroesophageal junction cancer. (2024 · Journal of Clinical Oncology · 被引 15)
• Therapeutic Effects of an Inhibitor of Thioredoxin Reductase on Liver Fibrosis by Inhibiting the Transforming Growth Factor-β1/Smads Pathway (2021 · Frontiers in Molecular Biosciences · 被引 12)
• Tecotabart vedotin in Claudin 18.2-positive advanced gastric/gastroesophageal junction cancer: A Bayesian phase 1/2 clinical trial (2025 · European Journal of Cancer · 被引 11)
• Lithium Cholesterol Sulfate: A Novel and Potential Drug for Treating Alzheimer’s Disease and Autism Spectrum Disorder (2022 · CNS & Neurological Disorders - Drug Targets · 被引 9)
• Effects of clarithromycin on the pharmacokinetics of tacrolimus and expression of CYP3A4 and P‐glycoprotein in rats (2023 · Fundamental and Clinical Pharmacology · 被引 8)